Merck AG thyroid symposium: Subclinical hyperthyroidism

Thyroid

Volumn 9, Issue 3, 1999, Pages 311-315

  Koutras, Demetrios A ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE; THYROTROPIN;

BONE DENSITY; CONFERENCE PAPER; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; LABORATORY DIAGNOSIS; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; BONE DISEASE; CARDIOVASCULAR DISEASE; FEMALE; MALE; MIDDLE AGED; PREVALENCE; REVIEW;

BONE DISEASES; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; PREVALENCE;

EID: 0033088773     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.311     Document Type: Conference Paper

References (42)

1. Chernova T, Gerasimov G, Goncharov N 1997 A new method for diagnosing subclinical hyperthyroidism in patients with suppressed TSH levels. 24th Annual Meeting of the European Thyroid Association, Munich, Germany, August 30-September 3, J Endocrinol Invest 20(Suppl to no. 5): Abstract 208, 104.
2. Rae P, Farrar J, Beckett G, Toft A 1993 Assessment of thyroid status in elderly people. Br Med J 307:177-180.
3. Surks MI, Ocampo E 1996 Subclinical thyroid disease. Am J Med 100:217-223.
4. Wang C, Crapo L 1997 The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26:189-218.
5. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Grimley Evans J, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: The Whickam Survey. Clin Endocrinol 7:481-493.
6. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET 1995 The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol 43:55-68.
7. Bagchi N, Brown TR, Parish RF 1990 Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 150:785-787.
8. Konno N, Yuri K, Taguchi H, Miura K, Taguchi S, Hagiwara K, Murakami S 1993 Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin Endocrinol 38:273-281.
9. Meier Ch, Roth CB, Kunz M, Guglielmetti M, Martina B, Huber P, Staub JJ 1997 Screening for new thyroid dysfunction in a primary care unit using a third-generation TSH assay. 24th Annual Meeting of the European Thyroid Association, Munich, Germany, August 30th-September 3rd. J Endocrinol Invest 20(Suppl to no. 5):Abstract 206, 103.
10. Parle JV, Franklyn JA, Cross KW, Jones CJ 1991 Prevalence and follow-up of abnormal thyrotropin concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 34:77-83.
11. Potesta P, Murolo R, Costantini S, Constantini S, Imperilo G, Giardina F, Guerrier G, De Meo S, Casalli N 1996 High prevalence of asymptomatic hypothyroidism and hyperthyroidism in hospitalized elderly females. Eur Rev Med Pharmacol Sci 18:129-133.
12. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PWF, Benjamin EJ, D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331: 1249-1252.
13. Sidlauskas V, Krasauskienè A, Jakubonienè N, Auksčtuolytè A, Mašanauskaitè D, Telksnys A 1997 Prevalence of thyroid disorders in Lithuania. 24th Annual Meeting of the European Thyroid Association Munich, Germany, August 30th-September 3rd. J Endocrinol Invest 20(Suppl to no. 5):Abstract 82, 41.
14. Charkes ND 1996 The many causes of subclinical hyperthyroidism. Thyroid 6:391-396.
15. Kasagi K, Takeuchi R, Misaki T, Kousaka T, Miyamoto S, Iida Y, Konishi J 1997 Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects. J Endocrinol Invest 20:183-188.
16. Kasagi K, Hatabu H, Takuda Y, Iida Y, Endo K, Konishi J 1988 Studies on thyrotropin receptor antibodies in patients with euthyroid Graves' disease. Clin Endocrinol 29:357-366.
17. Ross DS 1996 Subclinical thyrotoxicosis. In: Braverman LE, Utiger RD, (eds) Werner & Ingbar's The Thyroid, 7th ed. Lippincott-Raven, Philadelphia, New York, 1016-1020.
18. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G 1991 High incidence of multinodular toxic goiter in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: Comparative surveys of thyrotoxicosis epidemiology in East-Jutland, Denmark and Iceland. J Intern Med 229:415-420.
19. Horst W, Rosler H, Schneider C, Labbart A 1967 Three hundred six cases of toxic adenoma: Clinical aspects, findings in radioiodine diagnostics, radiochromatography and histology results of 131I and surgical treatment. J Nucl Med 8:515-521.
20. Hamburger JI 1980 Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 50:1089-1093.
21. Stott DJ, McLellan AR, Finlayson J, Chu P, Alexander WD 1991 Elderly patients with suppressed serum TSH normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. QJM 78:77-84.
22. Schlote B, Schaaf L, Schmidt R, Pohl T, Vardarli I, Schiebeler H, Zober MA, Usadel KH 1992 Mental and physical state in subclinical hyperthyroidism: Investigation in a normal working population. Biol Psychiatry 32:48-56.
23. Tseng KH, Walfish PG, Persaud JA, Gilbert BW 1989 Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status. J Clin Endocrinol Metab 69:633-638.
24. Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G, Saccà L, Bellastella A, Lombardi G 1993 Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77:334-338.
25. Biondi B, Fazio S, Carella C, Sabatini D, Amato G, Cittadini A, Bellastella A, Lombardi G, Saccà L 1994 Control of adrenergic overactivity by β-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab 78:1028-1033.
26. Fazio S, Biondi B, Carella C, Sabatini D, Cittadini A, Panza N, Lombardi G, Saccà L 1995 Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of β-blockade. J Clin Endocrinol Metab 80:2222-2226.
27. Biondi B, Serafino F, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M, Saccà L 1996 Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 81:4224-4228.
28. Szabolcs I, Dohan O, Bernard W, Feldkump J, Harster FA 1996 Increased mortality in chronically ill geriatric patients with suppressed TSH: A follow up study. 10th International Congress of Endocrinology, San Francisco, USA, June 12-15, Abstract P3-1053.
29. Koutras DA 1992 Thyroxine therapy: Benefits and risks. In: Mornex R, Jaffiol C, Leclère J (eds) Progress in Endocrinology: The Proceedings of the 9th International Congress of Endocrinology, Nice 1992. Parthenon Publishing Group, Lancs UK & New York, p 293-298.
30. Ross DS, Neer RM, Ridgway EC, Daniels GH 1987 Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 82:1167-1171.
31. Paul TL, Kerrigan J, Kelly A-M, Braverman LE, Baran DT 1988 Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 259:3137-3141.
32. Diamond T, Nery L, Hules I 1990 A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72:1184-1188.
33. Franklyn JA, Betteridge J, Daykin J, Holder R, Oates GD, Parle JV, Lilley J, Heath DA, Sheppard MC 1992 Long-term thyroxine treatment and bone mineral density. Lancet 340:9-13.
34. Bauer DC, Nevitt MC, Ettinger B, Stone K 1997 Low thyrotropin levels are not associated with bone loss in older women: A prospective study. J Clin Endocrinol Metab 82:2931-2936.
35. Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A 1994 Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 78:818-823.
36. Marcocci C, Golia F, Vignali E, Pinchera A 1997 Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine. J Bone Miner Res 12:72-77.
37. Faber J, Galloe AM 1994 Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: A meta-analysis. Eur J Endocrinol 130:350-356.
38. Uzzan B, Campos J, Cucherat M, Nony P, Poissel JP, Perret GV 1996 Effects on bone mass of long term treatment with thyroid hormones: A meta-analysis. J Clin Endocrinol Metab 81:4278-4289.
39. Solomon BL, Wartofsky L, Burman KD 1993 Prevalence of functions in postmenopausal women with thyroid disease. Thyroid 3:17-23.
40. Nolte W, Muller R, Siggelkow H, Emrich D, Hufner M 1996 Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: A randomized study. Eur J Endocrinol 134:337-341.
41. Utiger RD 1994 Subclinical hyperthyroidism - Just a low serum thyrotropin concentration, or something more? N Engl J Med 331:1302-1303.
42. Jayme JJ, Ladenson PW 1994 Subclinical thyroid dysfunction in the elderly. Trends Endocrinol Metab 5:79-86.